Centrica PLC Transaction in Own Shares
07 Januar 2025 - 8:00AM
RNS Regulatory News
RNS Number : 3097S
Centrica PLC
07 January 2025
|
Transactions in own
shares
Centrica plc
7 January
2025
Centrica plc announces that it
purchased on 6 January 2025 (through Goldman Sachs International)
2,048,600 Centrica plc ordinary shares of 6
14/81 pence each at a price of 136.7500 pence
per share. The purchased shares will be held as treasury shares.
Such purchase was effected pursuant to the Company's buyback
programme announced on 8 August 2024 and in accordance with the
non-discretionary share repurchase agreement entered into with
Goldman Sachs International and pursuant to the Company's buyback
programme update announced on 27 December 2024 and in accordance
with the separate non-discretionary agreement with Goldman Sachs
International.
Since 8 August 2024, Centrica has
purchased 138,748,102 ordinary shares at a cost (excluding dealing
and associated costs) of £170,328,347.88.
Following the above purchase, Centrica
plc holds 482,364,475 ordinary shares in treasury, and has
5,085,742,739 ordinary shares in issue (excluding treasury
shares).
In accordance with Article 5(1)(b) of
Regulation (EU) No 596/2014 (the Market Abuse Regulation) (as in
force in the UK and as amended by the Market Abuse (Amendment) (EU
Exit) Regulations 2019), detailed information about the individual
purchases made by Goldman Sachs International is set out
below.
Transaction details: Centrica plc ordinary shares of 6
14/81 pence each
|
|
|
|
|
|
|
|
|
|
Goldman Sachs
International
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of ordinary shares
purchased:
|
|
|
|
|
|
|
|
Volume weighted average price paid
per share:
|
|
|
|
|
Disaggregated information
The table attached contains detailed
information of the individual trades made by Goldman Sachs
International, as part of the buyback programme.
Click on, or paste the following link
into your web browser, to view the associated PDF
document.
http://www.rns-pdf.londonstockexchange.com/rns/3097S_1-2025-1-6.pdf
END
Enquiries:
Investors and Analysts
T: 01753 494900
E: ir@centrica.com
Centrica
plc is listed on the London Stock Exchange (CNA)
Registered Office: Millstream, Maidenhead Road, Windsor,
Berkshire SL4 5GD
Registered in England & Wales number: 3033654
Legal
Entity Identifier number: E26EDV109X6EEPBKVH76
ISIN
number: GB00B033F229
|
|
|
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
POSDZGGMNVKGKZM
Centrica (LSE:CNA)
Historical Stock Chart
Von Dez 2024 bis Jan 2025
Centrica (LSE:CNA)
Historical Stock Chart
Von Jan 2024 bis Jan 2025
